These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31833464)

  • 21. FRAMIG 2000: medical and therapeutic management of migraine in France.
    Lucas C; Chaffaut C; Artaz MA; Lantéri-Minet M
    Cephalalgia; 2005 Apr; 25(4):267-79. PubMed ID: 15773824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Modified Wuzhuyu Decoction Granule ( ) for Migraine Patients with Cold and Stasis Obstructing Meridian Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Liu HW; Zou YH; Cao KG; Yu LH; Zhang Y; Fu CH; Ma DY
    Chin J Integr Med; 2018 Jun; 24(6):409-414. PubMed ID: 28741060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial.
    MacGregor EA; Victor TW; Hu X; Xiang Q; Puenpatom RA; Chen W; Campbell JC
    Headache; 2010 Apr; 50(4):528-38. PubMed ID: 20236340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
    Headache; 2004; 44(7):678-83. PubMed ID: 15209690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early efficacy and late gain in chronic and high-frequency episodic migraine with onabotulinumtoxinA.
    Alpuente A; Gallardo VJ; Torres-Ferrus M; Alvarez-Sabin J; Pozo-Rosich P
    Eur J Neurol; 2019 Dec; 26(12):1464-1470. PubMed ID: 31220392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews.
    Gibson W; Wand BM; Meads C; Catley MJ; O'Connell NE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011890. PubMed ID: 30941745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial.
    Kumar A; Bhatia R; Sharma G; Dhanlika D; Vishnubhatla S; Singh RK; Dash D; Tripathi M; Srivastava MVP
    Neurology; 2020 May; 94(21):e2203-e2212. PubMed ID: 32376640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
    Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
    Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manual therapy as a prophylactic treatment for migraine: design of a randomized controlled trial.
    Amons AL; Castien RF; van der Wouden JC; De Hertogh W; Dekker J; van der Horst HE
    Trials; 2019 Dec; 20(1):785. PubMed ID: 31881911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.
    Stewart WF; Lipton RB; Whyte J; Dowson A; Kolodner K; Liberman JN; Sawyer J
    Neurology; 1999 Sep; 53(5):988-94. PubMed ID: 10496257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiating and optimizing acute therapy for migraine: the role of patient-centered stratified care.
    Diamond M; Cady R
    Am J Med; 2005 Mar; 118 Suppl 1():18S-27S. PubMed ID: 15841884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association of Changes in Pain Acceptance and Headache-Related Disability.
    Lillis J; Thomas JG; Lipton RB; Rathier L; Roth J; Pavlovic J; O'Leary KC; Bond DS
    Ann Behav Med; 2019 Jun; 53(7):686-690. PubMed ID: 30289426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing onabotulinumtoxinA injection due to chronic intractable migraine?
    Gandolfi M; Geroin C; Valè N; Marchioretto F; Turrina A; Dimitrova E; Tamburin S; Serina A; Castellazzi P; Meschieri A; Ricard F; Saltuari L; Picelli A; Smania N
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):1-12. PubMed ID: 28750504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial.
    Chaibi A; Benth JŠ; Tuchin PJ; Russell MB
    Eur J Neurol; 2017 Jan; 24(1):143-153. PubMed ID: 27696633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of osteopathic manipulative treatment of female patients with migraine: results of a randomized controlled trial.
    Voigt K; Liebnitzky J; Burmeister U; Sihvonen-Riemenschneider H; Beck M; Voigt R; Bergmann A
    J Altern Complement Med; 2011 Mar; 17(3):225-30. PubMed ID: 21385086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin A in chronic refractory migraine: premarketing experience].
    Álvaro-González LC; Fernández-García JM; Aranzábal-Alustiza I; Castillo-Calvo B; Iriondo-Etxenagusia I; Rodríguez-Antigüedad A
    Rev Neurol; 2012 Oct; 55(7):385-91. PubMed ID: 23011856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.